Company / Revenue
NEUROONE MEDICAL TECHNOLOGIES Corp Revenue History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$3.5M
FY2025
5-year range
$171.2K / $3.5M
FY2021-FY2025
Trend
+76.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 10 years, ranging from $0 in FY2016 to $3M in FY2025.
Based on SEC 10-K filings.
$3M in FY2025 with a 10-year CAGR of +131.7%.
Improved from $171,169 to $3M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +168.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- +131.7%
Key checks
Key Insights
- 3-year CAGR of +168.6%, indicating consistent growth.
- In FY2025, revenue increased 76.9% year-over-year.
- Lowest revenue in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.5M | +76.9% |
| FY2024 | $2.0M | +1040.7% |
| FY2023 | $171.2K | -3.9% |
| FY2022 | $178.1K | +0.0% |
| FY2021 | $178.1K | - |
| FY2016 | $0 | -100.0% |
| FY2015 | $773 | -38.1% |
| FY2014 | $1.2K | -76.9% |
| FY2012 | $5.4K | +362.6% |
| FY2011 | $1.2K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026